Senior insider sale
President and CEO at KYMERA THERAPEUTICS, INC. — senior position signals high conviction
$5.18M
60K shares
What this filing means
MAINOLFI NELLO plans to sell 60K shares of KYMERA THERAPEUTICS, INC. valued at approximately $5.18M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/29/2026ACC: 0001969223-26-000476
DirectorOfficer· President and CEO
Since Aug 2020
60K
Shares to sell
$5.18M
Approx. market value
30K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of stock options
Cash
4/29/2026
30KTotal acquired30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/29/2026 | Exercise of stock options Cash | 30K | — |
| Total | 30K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
30K
Market value
$2.71M
2/25/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
30K
Market value
$2.47M
4/29/2026
Total
Units
60K
Value
$5.18M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/25/2026 | 30K | $2.71M | — | Completed |
| Planned — Approximate Date | ||||
4/29/2026 | 30K | $2.47M | NASDAQ | Planned |
| Total | 60K | $5.18M | ||